Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Gigacloud Technology Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Gigacloud Technology Inc trades at $51 (market cap $1.84B). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 2.8× Gigacloud Technology Inc's market cap. Which is the better fit depends on your goals.
| ACAD | GCT | |
|---|---|---|
Market Cap | $5.07B | $1.84B |
Sector | Health | Technology |
52-Week High | $29.41 | $53.25 |
52-Week Low | $20.06 | $25.44 |
Enterprise Value | $4.19B | $1.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
